tradingkey.logo
tradingkey.logo
Search

Warby Parker Inc

WRBY
Add to Watchlist
28.480USD
+1.530+5.68%
Close 05/13, 16:00ETQuotes delayed by 15 min
3.49BMarket Cap
2674.18P/E TTM

Warby Parker Inc

28.480
+1.530+5.68%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Warby Parker Inc

Currency: USD Updated: 2026-05-12

Key Insights

Warby Parker Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 31 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 29.75.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Warby Parker Inc's Score

Industry at a Glance

Industry Ranking
31 / 206
Overall Ranking
112 / 4490
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Warby Parker Inc Highlights

StrengthsRisks
Warby Parker Inc. is a lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The Company offers holistic vision care by selling eyewear products and providing optical services directly to consumers through its retail stores and e-commerce platform. It sells a range of prescription and non-prescription eyewear, including glasses, sunglasses, and contact lenses. Its customers can customize their prescription lenses with a variety of options, including single-vision, progressive, light-responsive, blue-light-filtering, and non-prescription lenses. It also offers in-house technologies like Virtual Vision Test and Virtual Try-On to enhance the overall customer experience. It sells its own brand of contacts, Scout by Warby Parker, and third-party contact lenses; this allows it to provide customers with a vision care offering. Its Website and mobile app make it easy for its customers to browse, virtually try on, and purchase glasses.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 30.18% year-on-year.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Overvalued
The company’s latest PE is 2530.52, at a high 3-year percentile range.
Held by Tom Russo
Star Investor Tom Russo holds 65.00K shares of this stock.

Analyst Rating

Based on 14 analysts
Buy
Current Rating
29.750
Target Price
+0.68%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-05-12

The current financial score of Warby Parker Inc is 6.64, ranking 131 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 242.45M, representing a year-over-year increase of 8.34%, while its net profit experienced a year-over-year increase of 8.50%.

Score

Industry at a Glance

Previous score
6.64
Change
0

Financials

9.67

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

3.18

Operational Efficiency

7.63

Growth Potential

5.60

Shareholder Returns

7.11

Warby Parker Inc's Company Valuation

Currency: USD Updated: 2026-05-12

The current valuation score of Warby Parker Inc is 7.95, ranking 50 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 2530.52, which is 130.18% below the recent high of 5824.66 and 114.78% above the recent low of -373.97.

Score

Industry at a Glance

Previous score
7.95
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 31/206
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-05-12

The current earnings forecast score of Warby Parker Inc is 7.86, ranking 114 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 22.00, with a high of 27.00 and a low of 18.00.

Score

Industry at a Glance

Previous score
7.86
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 14 analysts
Buy
Current Rating
29.917
Target Price
+3.91%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

24
Total
6
Median
10
Average
Company name
Ratings
Analysts
Warby Parker Inc
WRBY
14
Tractor Supply Co
TSCO
31
Chewy Inc
CHWY
28
Ulta Beauty Inc
ULTA
28
DICK'S Sporting Goods Inc
DKS
26
Amer Sports Inc
AS
22
1
2
3
4
5

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-05-12

The current price momentum score of Warby Parker Inc is 9.23, ranking 19 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 30.84 and the support level at 22.10, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
9.58
Change
-0.35

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(3)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
1.314
Buy
RSI(14)
62.799
Neutral
STOCH(KDJ)(9,3,3)
78.715
Neutral
ATR(14)
1.905
High Vlolatility
CCI(14)
92.392
Neutral
Williams %R
15.912
Overbought
TRIX(12,20)
0.608
Sell
StochRSI(14)
34.783
Sell
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
28.196
Buy
MA10
25.186
Buy
MA20
24.401
Buy
MA50
23.558
Buy
MA100
24.385
Buy
MA200
23.933
Buy

Institutional Confidence

Currency: USD Updated: 2026-05-12

The current institutional shareholding score of Warby Parker Inc is 10.00, ranking 1 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 106.73%, representing a quarter-over-quarter decrease of 5.45%. The largest institutional shareholder is PRFDX, holding a total of 1.98M shares, representing 1.85% of shares outstanding, with 511.62% increase in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Fidelity Management & Research Company LLC
14.56M
+71.54%
Durable Capital Partners LP
7.31M
-16.48%
BlackRock Institutional Trust Company, N.A.
6.75M
-1.45%
JP Morgan Asset Management
6.15M
+34.23%
Vaughan Nelson Investment Management, L.P.
2.31M
-4.80%
Raider (Jeffrey Jacob)
4.15M
-0.60%
State Street Investment Management (US)
2.41M
+9.16%
Geode Capital Management, L.L.C.
2.30M
+0.51%
1
2

Risk Assessment

Currency: USD Updated: 2026-05-12

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Warby Parker Inc is 4.30, ranking 106 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.99. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. Warby Parker Inc’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.

Score

Industry at a Glance

Previous score
4.30
Change
0
Beta vs S&P 500 index
1.99
VaR
--
240-Day Maximum Drawdown
+42.26%
240-Day Volatility
+66.60%

Return

Best Daily Return
60 days
+23.47%
120 days
+27.35%
5 years
--
Worst Daily Return
60 days
-8.62%
120 days
-9.71%
5 years
--
Sharpe Ratio
60 days
+1.49
120 days
+1.48
5 years
--

Risk Assessment

Maximum Drawdown
240 days
+42.26%
3 years
+50.74%
5 years
--
Return-to-Drawdown Ratio
240 days
+0.81
3 years
+0.89
5 years
--
Skewness
240 days
+1.77
3 years
+0.92
5 years
--

Volatility

Realised Volatility
240 days
+66.60%
5 years
--
Standardised True Range
240 days
+4.89%
5 years
--
Downside Risk-Adjusted Return
120 days
+331.90%
240 days
+331.90%
Maximum Daily Upside Volatility
60 days
+86.39%
Maximum Daily Downside Volatility
60 days
+50.97%

Liquidity

Average Turnover Rate
60 days
+2.39%
120 days
+2.88%
5 years
--
Turnover Deviation
20 days
+13.94%
60 days
+24.58%
120 days
+49.95%

Peer Comparison

Healthcare Equipment & Supplies
Warby Parker Inc
Warby Parker Inc
WRBY
7.70 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
Lantheus Holdings Inc
LNTH
8.76 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
Anika Therapeutics Inc
ANIK
8.57 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LivaNova PLC
LIVN
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc
TMO
8.39 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bruker Corp
Bruker Corp
BRKR
8.30 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI